Effects of acetate-free haemodiafiltration (HDF) with endogenous reinfusion (HFR) on cardiac troponin levels

Nephrology Dialysis Transplantation

Volumn 26, Issue 1, 2011, Pages 258-263

  Bolasco, Piergiorgio ^a   Ghezzi, Paolo M ^b   Serra, Antonella ^a   Corazza, Luca ^b   Fundoni, Gian Franco ^c   Pistis, Raffaele ^d   Gazzanelli, Luana ^c   Piras, Angelo ^e   Accalai, Giampiero ^f   Calvisi, Luciangela ^e   Carpentieri, Elisabeth ^c   Contu, Rita ^a   Grussu, Sandro ^g   Mattana, Giovanni ^h   Pinna, Mario ⁱ   Scalas, M Rosa ^a   Sulis, Emiliana ^g  

^a Territorial Department of Nephrology and Dialysis   (Italy)

^b Scientific Affairs   (Italy)

^c ASL 2   (Italy)

^d ASL 7   (Italy)

^e ASL 1   (Italy)

^f Division of Nephrology and Dialysis   (Italy)

^g ASL 4   (Italy)

^h Presidio Ospedaliero S Francesco   (Italy)

ⁱ Neurology Unit   (Italy)

Author keywords

acetate free dialysis solutions; cardiac troponin; dialysis solutions; haemodiafiltration; haemodiafiltration with endogenous reinfusion; HFR

Indexed keywords

ACETIC ACID; ANTIANEMIC AGENT; BICARBONATE; BIOLOGICAL MARKER; DIALYSIS FLUID; IRON; TROPONIN;

ADULT; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE INJURY; HEART RATE; HEMODIAFILTRATION; HUMAN; HYPOTENSION; INFUSION; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REPEAT PROCEDURE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ULTRAFILTRATION;

ACETATES; AGED; BICARBONATES; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD VOLUME; BUFFERS; CARDIOVASCULAR DISEASES; FEMALE; HEART RATE; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME; TROPONIN C;

EID: 78650658982     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq359     Document Type: Article

References (27)

1. Löwbeer C, Seeberger AO, Gustafsson SA. Increased cardiac tropo-nin T and endothelin-1 concentrations in dialysis patients may indicate heart disease. Nephrol Dial Transplant 2001; 16: 1452-1458
2. Musso P, Cox I, Vidano E et al. Cardiac troponin elevations in chronic renal failure: prevalence and clinical significance. Clin Biochem 1999; 32: 125-130
3. De Filippi C, Wasserman S, Rosani S. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003; 290: 353-359
4. Manes MT, Gagliardi M, Misuraca GF et al. Left geometrical patterns and cardiac function in patients with chronic renal failure undergoing hemodialysis. Monaldi Arch Chest Dis 2005; 64: 27-32
5. Deléaval P, Descombes E, Magnin JL et al. Differences in cardiac troponin I and T levels measurement in asymptomatic hemodialysis patients with last-generation immunoassays. Nephrol Ther 2006; 2: 75-81
6. Sommerer C, Heckele S, Schwenger V et al. Cardiac biomarkers are influenced by dialysis characteristics. Clin Nephrol 2007; 68: 392-400
7. Katerinis I, Nguyen QV, Magnin JL et al. Cardiac findings in asymptomatic hemodialysis patients with persistently elevated cardiac troponin I levels. Ren Fail 2008; 30: 357-362
8. Apple FS, Sharkey SW, Hoeft P. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcome analysis. Am J Kidney Dis 1997; 29: 399-403
9. Porter GA, Norton T, Bennet WB. Troponin, T a predictor of death in chronic hemodialysis. Eur Heart J 1999; 19: 34-37
10. Illiou MC, Fumeron C, Benoit MO et al. Factors associated with increased serum levels of cardiac troponin T and I in chronic hemodialysis patients: Chronic Hemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant 2001; 16: 1452-1458
11. De Filippi CR, Thorn EM, Aggarwal M et al. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. Am J Cardiol 2007; 100: 885-889
12. Löwbeer C, Stenvinkel P, Pecoits-Filho R et al. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med 2003; 253: 153-160
13. Roberts MA, Hare DL, Macmillan N et al. Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic hemodialysis. Ann Clin Biochem 2009; 46: 291-295
14. Lippi G, Tessitore N, Montagnana M et al. Influence of sampling time and ultrafiltration coefficient of the dialysis membrane on cardiac troponin I and T. Arch Pathol Lab Med 2008; 132: 72-76
15. Pizzarelli F, Cerrai T, Dattolo P et al. On-line haemodiafiltration with and without acetate. Nephrol Dial Transplant 2006; 21: 1648-1651
16. Pizzarelli F. Paired hemodiafiltration. Contrib Nephrol 2007; 158: 131-137
17. Amore A, Cirina P, Mitola S et al. Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol 1997; 8: 1431-1436
18. Amore A, Conti G, Cirina P et al. Biocompatibility of the acetate in the dialysis fluid. G Ital Nefrol 2004; 21: S91-S96
19. Amore A, Cirina P, Bonaudo R et al. Bicarbonate dialysis, unlike acetate-free biofiltration, triggers mediators of inflammation and apoptosis in endothelial and smooth muscle cells. J Nephrol 2006; 19: 57-64
20. Noris M, Todeschini M, Casiraghi F et al. Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: implications for dialysis hypotension. Am J Kidney Dis 1998; 32: 115-124
21. Grandi E, Govoni M, Furini S et al. Induction of NO synthase 2 in ventricular cardiomyocytes incubated with a conventional bicarbonate dialysis bath. Nephrol Dial Transplant 2008; 23: 2192-2197
22. Selby NM, Fluck RJ, Taal MW et al. Effects of acetate-free double-chamber hemodiafiltration and standard dialysis on systemic hemodynamics and troponin T levels. ASAIO J 2006; 52: 62-69
23. Tomo T, Matsuyama K, Matsuyama M et al. Effects of on-line HDF with acetate-free dialysis fluid on prognostic factors for cardiovascular complications in maintenance hemodialysis patients. Milan: WCN (World Congress of Nephrology), 2009; Poster Sa 422
24. Wratten ML, Sereni L, Lupotti M et al. Optimization of a HFR sor-bent cartridge for high molecular weight uremic toxins. G Ital Nefrol 2004; 21: S67-S70
25. De Nitti C, Giordano R, Gervasio R et al. Choosing new sorbents for endogenous ultrapure infusion fluid: performances, safety and flow distribution. Int J Artif Organs 2001; 24: 765-776
26. Tetta C, Ghezzi PM, De Nitti C et al. New options for on-line hemo-diafiltration. Contrib Nephrol 2002; 137: 212-220
27. Wratten ML, Ghezzi PM. Hemodiafiltration with endogenous reinfu-sion. Contrib Nephrol 2007; 150: 94-102